James T. Glover has been appointed to the new position of senior vice president of operations and chief financial officer, Anadys Pharmaceuticals. He will be responsible for Anadys’ operational and financial activities and will report to Kleanthis G. Xanthopoulos, Ph.D., president and chief executive officer. Mr. Glover joins the company from Beckman Coulter, Inc., where he served as senior vice president and chief financial officer since 2003. During his 23-year tenure at Beckman Cou...